Search research articles
Contact Us
Filters
Showing results (1-10 of 45) with videos related to
Page
of 5
Sort By:
Expert Opinion on Investigational Drugs
|
February 19, 2019
Therapy of acute myeloid leukemia: therapeutic targeting of tyrosine kinases
Joseph Cioccio, David Claxton
Expert Opinion on Investigational Drugs
|
February 14, 2012
Obatoclax mesylate : pharmacology and potential for therapy of hematological neoplasms
Jamal Joudeh, David Claxton
Therapeutic Advances in Hematology
|
April 24, 2013
Clofarabine in the treatment of acute myeloid leukemia in older adults
Stephen Tiley, David Claxton
Blood Cells, Molecules & Diseases
|
July 10, 2003
Autologous immunotherapy for human leukemias
David Claxton, Shing Fen Kao
Journal of Physical Activity & Health
|
May 8, 2009
The effect of physical activity homework on physical activity among college students
David Claxton, Gayle M Wells
Experimental Hematology
|
June 23, 2020
AML chemoresistance: The role of mutant TP53 subclonal expansion and therapy strategy
Bowen Yan, David Claxton, Suming Huang, et al.
Advances in Experimental Medicine and Biology
|
January 5, 2013
Emerging molecular therapies for the treatment of acute lymphoblastic leukemia
Monali Vasekar, Joshua E Allen, Jamal Joudeh, et al.
Clinical Science (London, England : 1979)
|
January 10, 2003
Peripheral blood leucocyte functional responses to acute eccentric exercise in humans are influenced by systemic stress, but not by exercise-induced muscle damage
John M Saxton, David Claxton, Edward Winter, et al.
Journal of Exercise Rehabilitation
|
July 14, 2017
Kinematics and neuromuscular recruitment during vertical treadmill exercise
Alastair R Jordan, Andrew Barnes, David Claxton, et al.
Journal of Exercise Rehabilitation
|
March 8, 2018
Sprint interval training on the vertical treadmill improves aerobic and anaerobic running performance
Alastair Ross Jordan, David Claxton, Alison Purvis, et al.
Page
of 5
Search research articles
Search
Showing results (1-10 of 45) with videos related to
Sort By:
Page
of 5
Expert Opinion on Investigational Drugs
|
February 19, 2019
Therapy of acute myeloid leukemia: therapeutic targeting of tyrosine kinases
Joseph Cioccio, David Claxton
Expert Opinion on Investigational Drugs
|
February 14, 2012
Obatoclax mesylate : pharmacology and potential for therapy of hematological neoplasms
Jamal Joudeh, David Claxton
Therapeutic Advances in Hematology
|
April 24, 2013
Clofarabine in the treatment of acute myeloid leukemia in older adults
Stephen Tiley, David Claxton
Blood Cells, Molecules & Diseases
|
July 10, 2003
Autologous immunotherapy for human leukemias
David Claxton, Shing Fen Kao
Journal of Physical Activity & Health
|
May 8, 2009
The effect of physical activity homework on physical activity among college students
David Claxton, Gayle M Wells
Experimental Hematology
|
June 23, 2020
AML chemoresistance: The role of mutant TP53 subclonal expansion and therapy strategy
Bowen Yan, David Claxton, Suming Huang, et al.
Advances in Experimental Medicine and Biology
|
January 5, 2013
Emerging molecular therapies for the treatment of acute lymphoblastic leukemia
Monali Vasekar, Joshua E Allen, Jamal Joudeh, et al.
Clinical Science (London, England : 1979)
|
January 10, 2003
Peripheral blood leucocyte functional responses to acute eccentric exercise in humans are influenced by systemic stress, but not by exercise-induced muscle damage
John M Saxton, David Claxton, Edward Winter, et al.
Journal of Exercise Rehabilitation
|
July 14, 2017
Kinematics and neuromuscular recruitment during vertical treadmill exercise
Alastair R Jordan, Andrew Barnes, David Claxton, et al.
Journal of Exercise Rehabilitation
|
March 8, 2018
Sprint interval training on the vertical treadmill improves aerobic and anaerobic running performance
Alastair Ross Jordan, David Claxton, Alison Purvis, et al.
Page
of 5